Maxtra Tablet contains Chlorpheniramine Maleate 4mg and Phenylephrine 10mg, combining an antihistamine with a decongestant to provide effective relief from symptoms associated with allergic conditions and nasal congestion. Chlorpheniramine Maleate is a first-generation antihistamine that competitively inhibits H1 histamine receptors, thereby reducing allergic manifestations such as sneezing, itching, watery eyes, and runny nose. Phenylephrine, a selective alpha-1 adrenergic receptor agonist, acts as a nasal decongestant by causing vasoconstriction in the nasal mucosa, leading to decreased swelling and improved airflow. Maxtra Tablet is indicated for the symptomatic treatment of allergic rhinitis, hay fever, common cold, and sinusitis. It is particularly beneficial in patients experiencing nasal congestion accompanied by allergic symptoms. The tablet should be used as directed by a healthcare professional, with caution advised in individuals with hypertension, cardiovascular disease, hyperthyroidism, or glaucoma due to the vasoconstrictive properties of Phenylephrine. Common side effects may include dizziness, dry mouth, or mild gastrointestinal discomfort. Maxtra Tablet offers a convenient, dual-action approach to managing allergy-related nasal symptoms and congestion, enhancing patient comfort and quality of life.